跳至主要内容
临床试验/NCT00875498
NCT00875498已完成不适用

Intermittent Theta Burst Stimulation (iTBS) for the Treatment of Negative Symptoms in Schizophrenia

Hôpital le Vinatier1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2008年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
22
试验地点
1
主要终点
Scale for the Assessment of Negative Symptoms (SANS)

研究概览

简要总结

The purpose of this study is to determine whether the iTBS is an effective treatment of the negative symptoms of schizophrenia.

详细描述

This study will evaluate whether the intermittent Theta Burst Stimulation (iTBS), a new high frequency TMS protocol is efficient in the treatment of the Negative Symptoms of schizophrenia.

Neuroimaging studies demonstrate that hypoactivity in the left dorsolateral prefrontal cortex (LDLPFC) was associated with negative symptoms.

The investigators hypothesize that iTBS applied to LDLPFC will improve negative symptoms and will improve activity of the LDLPFC measured with Magnetic Resonance Spectroscopy (MRS).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Schizophrenia according to DSM-IV
  • Negative symptoms for at least 6 weeks
  • Medication resistance according to Kane et al., 1988
  • Age between 18 and 50 years old
  • Informed consent

排除标准

  • Contraindication to TMS
  • Pregnancy

结局指标

主要结局

Scale for the Assessment of Negative Symptoms (SANS)

时间窗: before, after 2 weeks of treatment, and 3 times follow-up (1, 3 and 6 months)

次要结局

  • Neurochemical impact of treatment measured by 1H-MRS, DTI and resting MRI(3 times, before treatment, immediatly after treatment and a last evaluation 3 months after)

研究者

发起方
Hôpital le Vinatier
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. E. Poulet

PUPH

Hôpital le Vinatier

研究点 (1)

Loading locations...

相似试验